HAROLD SHINE to Female
This is a "connection" page, showing publications HAROLD SHINE has written about Female.
Connection Strength
0.093
-
Neuroimmune processes associated with Wallerian degeneration support neurotrophin-3-induced axonal sprouting in the injured spinal cord. J Neurosci Res. 2013 Oct; 91(10):1280-91.
Score: 0.017
-
Immune activation is required for NT-3-induced axonal plasticity in chronic spinal cord injury. Exp Neurol. 2008 Feb; 209(2):497-509.
Score: 0.012
-
Expression of neurotrophin-3 promotes axonal plasticity in the acute but not chronic injured spinal cord. J Neurotrauma. 2006 Aug; 23(8):1254-60.
Score: 0.011
-
In situ expression of brain-derived neurotrophic factor or neurotrophin-3 promotes sprouting of cortical serotonergic axons following a neurotoxic lesion. J Neurosci Res. 2005 Nov 01; 82(3):404-12.
Score: 0.010
-
Neurotrophic factors expressed in both cortex and spinal cord induce axonal plasticity after spinal cord injury. J Neurosci Res. 2003 Oct 15; 74(2):221-6.
Score: 0.009
-
Stroke Recovery in Rats after 24-Hour-Delayed Intramuscular Neurotrophin-3 Infusion. Ann Neurol. 2019 01; 85(1):32-46.
Score: 0.006
-
Adenoviral-mediated thymidine kinase gene transfer into the primate brain followed by systemic ganciclovir: pathologic, radiologic, and molecular studies. Hum Gene Ther. 1996 Jun 20; 7(10):1241-50.
Score: 0.005
-
Delayed intramuscular human neurotrophin-3 improves recovery in adult and elderly rats after stroke. Brain. 2016 Jan; 139(Pt 1):259-75.
Score: 0.005
-
Adenovirus-mediated gene therapy in an experimental model of breast cancer metastatic to the brain. Hum Gene Ther. 1995 Oct; 6(10):1317-22.
Score: 0.005
-
Adenovirus-mediated gene therapy for experimental spinal cord tumors: tumoricidal efficacy and functional outcome. Brain Res. 1995 Sep 11; 691(1-2):76-82.
Score: 0.005
-
Adenovirus-mediated gene therapy of experimental gliomas. J Neurosci Res. 1994 Nov 01; 39(4):506-11.
Score: 0.005
-
Effect of selective ablation of proliferating mammary epithelial cells on MNU induced rat mammary tumorigenesis. Breast Cancer Res Treat. 2002 May; 73(1):75-83.
Score: 0.002
-
Phase I study of adenoviral delivery of the HSV-tk gene and ganciclovir administration in patients with current malignant brain tumors. Mol Ther. 2000 Feb; 1(2):195-203.
Score: 0.002